Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
Clinical and experimental rheumatology, cilt.42, ss.130-137, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 42
- Basım Tarihi: 2024
- Doi Numarası: 10.55563/clinexprheumatol/2h6ma1
- Dergi Adı: Clinical and experimental rheumatology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, Veterinary Science Database
- Sayfa Sayıları: ss.130-137
- Gazi Üniversitesi Adresli: Evet